维普中文期刊产品整合服务
134篇 您的检索式:作者名="Holleran"
    题名 作者 年代 出处 被引量
1Molecular detection of Helicobacter pylori antibiotic resistance in stool vs biopsy samples显示文摘AIM To compare(1) demographics in urea breath test(UBT) vs endoscopy patients; and(2) the molecular detection of antibiotic resistance in stool vs biopsy samples.METHODS Six hundred and sixteen adult patients undergoing endoscopy or a UBT were prospectively recruited to the study. The Geno Type Helico DR assay was used to detect Helicobacter pylori(H. pylori) and antibiotic resistance using biopsy and/or stool samples from CLOpositive endoscopy patients and stool samples from UBT-positive patients. RESULTS Infection rates were significantly higher in patients referred for a UBT than endoscopy(overall rates: 33% vs 19%; treatment-na?ve patients: 33% vs 14.7%, respectively). H. pylori-infected UBT patients were younger than H. pylori-infected endoscopy patients(41.4 vs 48.4 years, respectively, P < 0.005), with a higher percentage of H. pylori-infected males in the endoscopy-compared to the UBT-cohort(52.6% vs 33.3%, P = 0.03). The Geno Type Helico DR assay was more accurate at detecting H. pylori infection using biopsy samples than stool samples [98.2%(n = 54/55) vs 80.3%(n =53/66), P < 0.005]. Subset analysis using stool and biopsy samples from CLO-positive endoscopy patients revealed a higher detection rate ofresistance-associated mutations using stool samples compared to biopsies. The concordance rates between stool and biopsy samples for the detection of H. pylori DNA, clarithromycin and fluoroquinolone resistance were just 85%, 53% and 35%, respectively. CONCLUSION Differences between endoscopy and UBT patients provide a rationale for non-invasive detection of H. pylori antibiotic resistance. However, the Geno Type Helico DR assay is an unsuitable approach.Denise E Brennan Joseph Omorogbe Mary Hussey Donal Tighe Grainne Holleran Colm O'Morain Sinéad M Smith Deirdre McNamara 2016World Journal of Gastroenterology2016,22,41:6
2Assessment of serum angiogenic factors as a diagnostic aid for small bowel angiodysplasia in patients with obscure gastrointestinal bleeding and anaemia显示文摘AIM To assess the use of serum levels of angiopoietin-1(Ang1), Ang2 and tumor necrosis factor-α(TNFα) as predictive factors for small bowel angiodysplasia(SBA).METHODS Serum samples were collected from patients undergoing capsule endoscopy for any cause of obscure gastrointestinal bleeding(OGIB) or anaemia. Based on small bowel findings patients were divided into 3 groups:(1) SBA;(2) other bleeding causes; and(3) normal, according to diagnosis. Using ELISA technique we measured serum levels of Ang1, Ang2 and TNFα and compared mean and median levels between the groups based on small bowel diagnosis. Using receiver operator curve analysis we determined whether any of the factors were predictive of SBA.RESULTS Serum samples were collected from a total of 120 patients undergoing capsule endoscopy for OGIB or anaemia: 40 with SBA, 40 with other causes of small bowel bleeding, and 40 with normal small bowel findings. Mean and median serum levels were measured and compared between groups; patients with SBA had significantly higher median serum levels of Ang2(3759 pg/mL) compared to both other groups, with no significant differences in levels of Ang1 or TNFα based on diagnosis. There were no differences in Ang2 levels between the other bleeding causes(2261 pg/mL) and normal(2620pg/mL) groups. Using Receiver Operator Curve analysis, an Ang2 level of > 2600 pg/mL was found to be predictive of SBA, with an area under the curve of 0.7. Neither Ang1 or TNFα were useful as predictive markers.CONCLUSION Elevations in serum Ang2 are specific for SBA and not driven by other causes of bleeding and anaemia. Further work will determine whether Ang2 is useful as a diagnostic or prognostic marker for SBA.Grainne Holleran Mary Hussey Sinead Smith Deirdre McNamara 2017World Journal of Gastrointestinal Pathophysiology2017,8,3:3
3A prospective 52week mucosal healing assessment of small bowel Crohn’s disease as detected by capsule endoscopy显示文摘Barry Hall Grainne Holleran Jun-Liong Chin Sinead Smith Barbara Ryan Nasir Mahmud Deirdre McNamara 2014Journal of Crohn’s and Colitis2014,,:3
4Measurements of Acute Cerebral Infarction: A Clinical Examination Scale显示文摘Thomas Brott Harold P. Adams Charles P. Olinger John R. Marler William G. Barsan José Biller Judith Spilker Renee Holleran Robert Eberle Vicki Hertzberg Marvin Rorick Charles J. Moomaw Michael Walker 1989Stroke1989,,7:2
5Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation 显示文摘Treister NS Woo SB O'Holleran EW 2005Biol Blood Marrow Transplant2005,11,9:1
6Difficult venous access in children:taking control显示文摘Kuensting LL DeBoer S Holleran R 0,,05:1
7Effects of dynamic step- ping training on nonlocomotor tasks in individuals poststroke显示文摘Straube DD Holleran CL Kinnaird CR 2014Phys Ther2014,94,7:1
8Inhibition of human scleral fibroblast proliferation with heparin显示文摘Del Vecchio PJ Bizios R Holleran LA 1988Invest Ophthalmol Vis Sci1988,29,:1
9Private incentives foradopting food safety and quality assurance显示文摘Holleran E M E Bredahl L Zaibet 1999Food Policy1999,,24:1
10Complexity of the thoracic spine pedicle anatomy显示文摘Panjabi MM O Holleran JD Crisco JJ 3rd 1997Eur Spine J1997,6,1:1
11Internal architecture of the thoracic pediele显示文摘Kothe R O'Holleran J Liu W 1996Spine1996,21,:1
12Small bowel angiodysplasia and novel disease associations: a cohort study显示文摘Grainne Holleran Barry Hall Mary Hussey Deirdre McNamara 2013Scandinavian Journal of Gastroenterology2013,,4:1
13Autonomic nervous system influences on QT interval in normal subjects显示文摘Magnano AR Holleran S Ramakrishnan R 2002J Am Coll Cardiol2002,39,11:1
14Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance显示文摘Elizabeth R. Glaze Amy L. Lambert Adaline C. Smith John G. Page William D. Johnson David L. McCormick Alan P. Brown Barry S. Levine Joseph M. Covey Merrill J. Egorin Julie L. Eiseman Julianne L. Holleran Edward A. Sausville Joseph E. Tomaszewski 2005Cancer Chemotherapy and Pharmacology2005,,6:1
15Properties of polymer modified binders and relationship to mix and pavement performance显示文摘MACCARRONE S HOLLERAN G GNANASEELAN G P 1995AAPT1995,76,:1
16Characterization of Angiotensin II Molecular Determinants Involved in AT1 Receptor Functional Selectivity显示文摘Domazet I Holleran B J Richard A 2015Mol Pharmacol2015,87,6:1
17Inhibition of human scleral fibroblast proliferation with heparin显示文摘Del Vecehio PJ Bizios R Holleran LA 0,,:1
18Change in lipid profile in celiac disease:beneficial effect of gluten-free diet显示文摘Brar P Kwon GY Holleran S 2006Am J Med2006,119,9:1
19Barrier function regulates ep- idermal lipid and DNA synthesis 显示文摘Proksch E Holleran WM Menon GK 1993Br J Dermatol1993,128,5:1
20Internal architecture ofthe thoracic pedicle显示文摘Kothe R O′ Holleran J Liu W 1996Spine1996,21,3:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费